Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
These outcomes are typically evaluated using migration assays, actin filament staining, and kinase phosphorylation analysis
Siebenhaar F, Frtsch A, Krause K, Weller K, Metz M, Magerl M, et al
Home Shop Research Guides Calculator About FAQ Cart Welcome to Advance Peptides
The nutrient is then absorbed directly into the bloodstream, bypassing any potential barriers in the digestive system